-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.P1.39 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, antibodies, Biological, Leukemia, bone marrow, Diseases, Lymphoma (any), Non-Biological, cell regulation, GVHD, Hodgkin Lymphoma, Therapies, Adverse Events, cellular interactions, checkpoint inhibitors, MDS, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Biological Processes, cell expansion, immune cells, Immune Disorders, Technology and Procedures, Cell Lineage, immunotherapy, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, hematopoiesis, pharmacology, flow cytometry, immune mechanism, transplantation, inflammation, molecular testing, stem cells, vaccines, RNA sequencing
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Ryotaro Nakamura, M.D.1, Corinna La Rosa, Ph.D.2*, Ibrahim Aldoss, M.D.1, Qiao Zhou, B.S.2*, Chetan Raj Lingaraju, M.S.2*, Joy Martinez, M.S.2*, Teodora Kaltcheva, PhD2* and Don J. Diamond, PhD2*

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
2Beckman Research Institute, City of Hope, Duarte, CA

Emmanuelle Godefroy1*, Patrice Chevallier, MD, PhD2, Thierry Guillaume, MD, PhD3,4*, Pierre Peterlin, MD5*, Alice Garnier, MD6*, Amandine Le Bourgeois, MD6*, Annabelle Pédron1*, Frédéric Altare, PhD1* and Francine Jotereau, PhD1,7*

1CRCINA - INCIT Immunology Department - IRS-2, INSERM U1232, Nantes, France
2Hematology Clinic, CHU Nantes, Nantes, France
3CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
4Department of Haematology, Nantes University Hospital, Nantes, France
5Nantes University Hospital, Department of Haematology, Nantes, France
6Clinical Hematology, Nantes University Hospital, Nantes, France
7University of Nantes, Nantes, France

Muhammad Ashar Ali, MD1*, Muhammad Yasir Anwar1*, Sobia Aamir, MD, FCPS2*, Saad Ur Rahman, MBBS1*, Richi Kashyap, MD3*, Sana Irfan Khan, MD4*, Usman Ali Akbar, MBBS5*, Anum Waqar, MBBS6*, Anam Khan7*, Wajeeha Aiman, MD5* and Faiz Anwer, MD8

1King Edward Medical University, Lahore, Pakistan
2Children hospital and Institute of Child Health, Lahore, Pakistan
3Maulana Azad Medical College, New Delhi, India
4All India Institute Of Medical Sciences, Delhi, India
5Nishtar Medical University, Multan, Pakistan
6Fatima Jinnah Medical University, Lahore, Pakistan
7Jawaharlal Nehru Medical College, Delhi, India
8Taussig Cancer Institute, Cleveland Clinic, Cleveland

Maude Dumont-Lagacé1,2*, Qi Li3*, Mégane Tanguay, MD2,4*, Jalila Chagraoui, PhD2*, Tibila Kientega5*, Guillaume Cardin5*, Ann Brasey, PhD.3*, Assya Trofimov, MSc2,6*, Cédric Carli, PhD3*, Imran Ahmad, MD7,8, Nadia M. Bambace, MD7,8, Léa Bernard, MD7,8, Thomas L. Kiss, MD7,8, Jean Roy, MD7,8, Denis-Claude Roy, MD3,7,8, Sébastien Lemieux, Ph.D.2,6,9*, Claude Perreault, MD2,8, Francis Rodier, PhD5,10*, Simon Frédéric Dufresne, MD, FRCP11,12*, Lambert Busque, MD5,7,13, Silvy Lachance, MD, FRCP7,8, Guy Sauvageau, MD Ph.D.1,2,7,8, Sandra Cohen, MD, FRCP(C)7,8 and Jean-Sébastien Delisle, MD, PhD3,7,8

1ExCellThera, Montreal, QC, Canada
2Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada
3Centre de recherche de l’Hôpital Maisonneuve-Rosemont, CIUSSS de l'Est-de-l'Île-de-Montréal, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
4Department of Medicine, McGill University, Montreal, QC, Canada
5Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada
6Department of Computer Science and Operations Research, Université de Montréal, Montreal, QC, Canada
7Division of Hematology-Oncology, CIUSSS de l'Est-de-l'Île-de-Montréal, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
8Department of Medicine, Université de Montréal, Montreal, QC, Canada
9Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, Canada
10Department of Radiology, Radio-Oncology and Nuclear Medicine, Université de Montréal, Montreal, QC, Canada
11Division of Infectious Diseases, Department of Internal Medicine, Hôpital Maisonneuve-Rosemont, Montreal, Canada
12Department of Microbiology, Infectious Diseases and Immunology, Universté de Montréal, Montreal, QC, Canada
13Université de Montréal, Montreal, QC, Canada

Fan Yang1*, Yang LEI, MD2*, Qinlong Zheng, PHD3*, Caiyan Zhang, PHD4*, Yueqian Feng, MD2*, Changwei Dong, MD5*, Zhihui Li1*, Yongqiang Zhao, MD1*, Yanzhi Song, MD1* and Tong Wu, MD1

1Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China
2Bone Marrow Transplantation, Beijing Borenhospital, Beijing, China
3Laboratory of Molecular Diagnostics, Beijing Boren Hospital, Beijing, China
4Laboratory of Molecular Diagnostics, Beijing Borenhospital, Beijing, China
5Bone Marrow Transplantation, Beijing borenhospital, Beijing, China

Dhanya Kizhakayil1*, Abbirami Sathappan, MS1*, Giusy Gentilcore, PhD1*, Zoltan Pos, PhD2*, Nikolett Lupsa, PhD2*, Mohammed A Al-Aghbar, PhD1*, Cristina Maccalli, PhD1*, Nicholas Van Panhuys, PhD1*, Jean-Charles Grivel3* and Sara Deola, MD, PhD1

1Research, Sidra Medicine, Doha, Qatar
2Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary
3Research, Sidra Medicine, Doha, MD, Qatar

Parameswaran Hari, MBBS, MD1, Haris Ali, MD2, Yi-Bin Chen, MD3, Salman Fazal, MD4, Tara K. Gregory, MD5*, Sarah M. Anand, MD6*, Ahmad Naim, MD7, Dilan Paranagama, PhD7*, Valkal Bhatt, PharmD7*, Amy Blithe, RD7* and John F. DiPersio, MD8

1Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI
2City of Hope Medical Center, Duarte, CA
3Massachusetts General Hospital, Boston, MA
4Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
5Colorado Blood Cancer Institute, Denver, CO
6University of Michigan, Ann Arbor, MI
7Incyte Corporation, Wilmington, DE
8Washington University School of Medicine in St. Louis, St. Louis, MO

Thuy N. Ho, MD1*, Maheen Khan, MS1*, Bennett Clark1*, Elizabeth Krieger, MD2, Catherine H Roberts, PhD1* and Amir Ahmed Toor, MD1*

1Department of Internal Medicine, Virginia Commonwealth University Health System, Richmond, VA
2Department of Pediatrics, Virginia Commonwealth University Health System, St Louis Park, MN

Aliana Meneses Ferreira, MD1, Vinicius Campos Molla, MD1,2*, Maria Cristina Nunez Seiwald, MD1,2*, Roberta Shcolnik Szor, MD1*, Pedro Henrique Arruda De Moraes, MD1,2*, Ana Rita Da Fonseca, MD1,2*, Mariana Serpa, MD1*, Erick Menezes Xavier, MD1*, Luciana Tucunduva, MD1*, Yana Novis, MD1* and Celso Arrais-Rodrigues, MD, PhD1,2

1Hospital Sírio Libanês, São Paulo, Brazil
2Department of Hematology and Hemotherapy, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil

Amany R. Keruakous, MD, George Selby, MD*, Sarah A. Schmidt, PharmD*, Jennifer Holter-Chakrabarty, MD*, Mohamad O. Khawandanah, MBBS, Jennifer Steward, PharmD*, Silas Day* and Carrie Yuen, MD

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Anastasiya Beynarovich1*, Kirill Lepik2*, Evgenia Borzenkova2*, Elena Kondakova2*, Elena Babenko2*, Nikita P. Volkov1*, Ivan S. Moiseev2*, Aleksander Kulagin2*, Natalia B. Mikhailova, MD, PhD2* and Marina O. Popova, MD, PhD2

1RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
2RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation

Amandine Pradier, PhD1*, Adrien Petitpas2*, Anne-Claire Mamez, MD1*, Federica Giannotti, MD1*, Sarah Morin, MD, PhD1*, Elif Mahne, MD1*, Yan Beauverd, MD1*, Mitja Nabergoj1*, Carmen De Ramon Ortiz, MD1*, Maria Anastasiou, MD1, Maria Mappoura, MD1*, Thien-An Tran, MD1*, Christian Ayer, MD1*, Anna Petropoulou, MD1*, Benjamin Bruno, MD1*, Paraskevi Stakia, MD1*, Laura Bounaix, MD1*, Stavroula Masouridi-Levrat, MD3*, Federico Simonetta, MD, PhD1* and Yves Chalandon, MD1

1Geneva University Hospitals, Geneva, Switzerland
2University of Geneva, Geneva, Switzerland
3Département d’Oncologie, Service d’Hématologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland

Najla El Jurdi, MD1*, Heba Elhusseini, MD2*, Todd E. DeFor, MS3*, Grigori Okoev, MD, PhD4, Aleksandr Lazaryan, MD, PhD, MPH5, John Rogosheske, PharmD6*, Kristen Weiler6*, Veronika Bachanova, MD, PhD7, Brian C. Betts, MD7, Bruce R. Blazar, MD8, Claudio G. Brunstein, MD, PhD7, Fiona He, MD9, Shernan G Holtan, MD7, Murali Janakiram, MD10, Radhika Gangaraju, MD11, Joseph E. Maakaron, MD7, Margaret L. MacMillan, MD12, Armin Rashidi, MD, PhD13, Erica D. Warlick, MD7, Smita Bhatia, MD, MPH14, Joan D. Beckman, MD, PhD15, Gregory M Vercellotti, MD16, Daniel J. Weisdorf, MD2 and Mukta Arora, MD7

1University of Minnesota, Minneapolis, MN
2Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
3Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
4Division of Hematology, Oncology and Transplantation, University of Minnesota, Edina, MN
5Hematology, Oncology and Transplantation, Moffitt Cancer Center, Tampa, FL
6Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN
7Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
8Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
9Unniversity of Minnesota, Minneapolis, MN
10Division of Hematology, Oncology and Transplantation, University of Minnesota, Rochester, MN
11Division of Hematology and Oncology, Department of Medicine, University Of Alabama at Birmingham, Birmingham, AL
12Division of Pediatric Blood and Marrow Transplantation, University Of Minnesota, Minneapolis, MN
13Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Edina, MN
14Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
15University of Minnesota Twin Cities, Minneapolis, MN
16Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN

*signifies non-member of ASH